Synucure Therapeutics Synucure Therapeutics inc. is a Canadian biotechnology company conducting research in brain degenerative disorders. Synucure was founded in 2021 with the key objective to pursue the promising and robust pre-clinical work of Dr. Francesca Cicchetti on Cysteamine which demonstrated, in various animal and cell models, that it could prevent and/or reverse a number